Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

RET-oncogene-targeting drugs draw notice.

Nature biotechnology - 9 Nov 2017

Abstract excerpt

No abstract is available from the source.

Topics

Join the communities discussing this publication.

Anilides
Antineoplastic Agents
Drug Delivery Systems
Mutation
Neoplasms
Oncogene Proteins, Fusion
Proto-Oncogene Proteins c-ret
Pyridines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29121012
DOI: 10.1038/nbt1117-996

Genes

RET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RET-oncogene-targeting drugs draw notice.PMID 29121012Read ↗

RET aberrant cancers and RET inhibitor therapies: Current state-of-the-art and future perspectivesSemantic proximity Read ↗

RET Signaling Pathway in Human Cancer: Oncogenic Mechanisms, Selective Inhibitors, and Emerging Resistance Strategies.Semantic proximity Read ↗

Oncogenes for the oncologist.Semantic proximity Read ↗

Targeting RET alterations in cancer: Recent progress and future directions.Semantic proximity Read ↗

Thyroid cancer in 2010: a roadmap for targeted therapies.Semantic proximity Read ↗

RET Inhibitors in RET Fusion-Positive Lung Cancers: Past, Present, and Future.Semantic proximity Read ↗

Precision oncology for RET-related tumorsSemantic proximity Read ↗

State-of-the-Art Strategies for Targeting RET -Dependent CancersSemantic proximity Read ↗

[Cancer targeted therapy and resistance signals].Semantic proximity Read ↗

Hyperactivation of oncogenic driver pathways as a precision therapeutic strategy.Semantic proximity Read ↗

Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations.Semantic proximity Read ↗

Precision Targeted Therapy with BLU-667 for RET-Driven Cancers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.